Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Esteve Química
Barcelona, Catalonia, Spainesteve.com ↗
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Other
01
Overview
Esteve Química operates as a CDMO focused on contract development and manufacture of small molecule APIs, HPAPIs, and pharma intermediates globally, with several approved drugs and commercial manufacturing for originators. The parent group, ESTEVE, is expanding into rare diseases, oncology, and endocrinology through acquisitions and licensing agreements[1][2][4][5][7].
- Therapeutic areas
- HematologyOncologyNeurologyEndocrinology
- Modalities
- Small moleculeEnzymeSynthetic peptideAAV based gene therapy
- Industry
- Contract Manufacturing Organization
02
Partnerships
Licensing agreement for severe primary insulin-like growth factor 1 deficiency biologic[1]
Beyond the preview
Go deeper on Esteve Química.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Esteve Química.